載入...
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial
PURPOSE: Pembrolizumab is active in melanoma, but activity in patients with untreated brain metastasis is less established. We present long-term follow-up of pembrolizumab-treated patients with new or progressing brain metastases treated on a phase II clinical trial (ClinicalTrials.gov identifier: N...
Na minha lista:
發表在: | J Clin Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
American Society of Clinical Oncology
2019
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354772/ https://ncbi.nlm.nih.gov/pubmed/30407895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00204 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|